Wash your hands and attach a fresh needle
Timelines vary, but many patients begin to notice changes in 24 weeks, such as reduced soreness, better range of motion, or quicker recovery after activity
Brning A et al
Most common adverse reactions for Wegovy (semaglutide) The most common adverse reactions for Wegovy (incidence 5%) are nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss
As a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously , the purity demands are higher than single-target peptides